The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

Immunotherapies have emerged as one of the most promising approaches to treat patients with cancer. Recently, the entire medical oncology field has been revolutionized by the introduction of immune checkpoints inhibitors. Despite success in a variety of malignancies, responses typically only occur i...

Descripción completa

Detalles Bibliográficos
Autores principales: Masucci, Giuseppe V., Cesano, Alessandra, Eggermont, Alexander, Fox, Bernard A., Wang, Ena, Marincola, Francesco M., Ciliberto, Gennaro, Dobbin, Kevin, Puzanov, Igor, Taube, Janis, Wargo, Jennifer, Butterfield, Lisa H., Villabona, Lisa, Thurin, Magdalena, Postow, Michael A., Sondel, Paul M., Demaria, Sandra, Agarwala, Sanjiv, Ascierto, Paolo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670700/
https://www.ncbi.nlm.nih.gov/pubmed/29100546
http://dx.doi.org/10.1186/s12967-017-1325-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670700/
https://www.ncbi.nlm.nih.gov/pubmed/29100546
http://dx.doi.org/10.1186/s12967-017-1325-2

Ejemplares similares